DeepMed Research

TUFTS MEDICAL CENTER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Mechanism of Action Study for Psoriasis

Phase 4

Completed

Conditions: Psoriasis

Interventions: Drug: Adalimumab (Humira)
Drug: Methotrexate

First Posted Date: 2009-07-03

Last Posted Date: 2017-08-31

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 33

Registration Number: NCT00932113

Locations: 🇺🇸
Tufts Medical Center, Department of Dermatology, Boston, Massachusetts, United States

Study of Apremilast in Atopic or Contact Dermatitis

Phase 2

Completed

Conditions: Atopic Dermatitis
Allergic Contact Dermatitis

Interventions: Drug: Apremilast

First Posted Date: 2009-07-02

Last Posted Date: 2010-12-20

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 10

Registration Number: NCT00931242

Locations: 🇺🇸
Tufts Medical Center, Department of Dermatology, Boston, Massachusetts, United States

Peds Metabolic Syndrome in Psoriasis

Completed

Conditions: Psoriasis
Metabolic Syndrome

First Posted Date: 2009-06-30

Last Posted Date: 2019-04-16

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 42

Registration Number: NCT00930592

Locations: 🇺🇸
Tufts Medical Center, Department of Dermatology, Boston, Massachusetts, United States

Fluphenazine Hydrochloride for Psoriasis

Phase 2

Completed

Conditions: Psoriasis

Interventions: Drug: Placebo
Drug: Fluphenazine

First Posted Date: 2009-06-29

Last Posted Date: 2017-03-31

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 15

Registration Number: NCT00929578

Locations: 🇺🇸
Tufts Medical Center, Department of Dermatology, Boston, Massachusetts, United States
🇺🇸
Robert Wood Johnson Medical School, Psoriasis Center of Excellence, New Brunswick, New Jersey, United States

HIV and Kidney Function Study

Completed

Conditions: AIDS
HIV Infections

First Posted Date: 2009-05-20

Last Posted Date: 2017-03-15

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 206

Registration Number: NCT00905151

Locations: 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States

Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy

Phase 4

Completed

Conditions: Myocardial Fibrosis
Hypertrophic Cardiomyopathy

Interventions: Drug: Placebo
Drug: Spironolactone

First Posted Date: 2009-04-09

Last Posted Date: 2021-04-27

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 53

Registration Number: NCT00879060

Locations: 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States

Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation

Phase 2

Completed

Conditions: Acute Respiratory Failure

Interventions: Drug: Placebo
Drug: Dexmedetomidine

First Posted Date: 2009-03-30

Last Posted Date: 2017-12-18

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 36

Registration Number: NCT00871624

Locations: 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States
🇺🇸
Winchester Hospital, Winchester, Massachusetts, United States

Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis

Not Applicable

Terminated

Conditions: Arthritis, Juvenile Rheumatoid
Still's Disease, Juvenile Onset

Interventions: Biological: tocilizumab

First Posted Date: 2009-03-25

Last Posted Date: 2017-05-15

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 1

Registration Number: NCT00868751

Locations: 🇺🇸
Tufts Medical Center/Floating Hospital for Children, Boston, Massachusetts, United States

Evaluating for Contact Allergies in Patients With Chronic Urticaria

Completed

Conditions: Allergy
Contact Sensitization
Urticaria
Patch Testing
Dermatitis

Interventions: Procedure: Patch Testing

First Posted Date: 2009-03-24

Last Posted Date: 2019-09-11

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 23

Registration Number: NCT00868036

Locations: 🇺🇸
Tufts Medical Center, Department of Dermatology, Boston, Massachusetts, United States

Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip

Phase 4

Completed

Conditions: Actinic Cheilitis
Squamous Cell Carcinoma In-situ (SCC-is)
Squamous Cell Carcinoma (SCC)
Photodynamic Therapy (PDT)
Mohs Surgery

Interventions: Procedure: PDT prior to Mohs surgery

First Posted Date: 2009-03-24

Last Posted Date: 2011-07-06

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 34

Registration Number: NCT00868088

Locations: 🇺🇸
Tufts Medical Center, Department of Dermatology, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy